Reducing  	Reducing  	 VBG	O
confounding  	confounding  	 NNS	O
and  	and  	 CC	O
suppression  	suppression  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
in  	in  	 IN	O
TCGA  	TCGA  	 NNP	B-NP
data 	data 	 NNS	I-NP
:  	:  	 :	O
an  	an  	 DT	O
integrated  	integrated  	 JJ	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
chemotherapy  	chemotherapy  	 JJ	B-NP
response  	response  	 NN	I-NP
in  	in  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
Despite  	Despite  	 IN	O
initial  	initial  	 JJ	O
response  	response  	 NN	O
in  	in  	 IN	O
adjuvant  	adjuvant  	 JJ	B-NP
chemotherapy 	chemotherapy 	 NN	I-NP
,  	,  	 ,	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
patients  	patients  	 NNS	I-NP
treated  	treated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
paclitaxel  	paclitaxel  	 NN	B-NP
and  	and  	 CC	O
carboplatin  	carboplatin  	 VBP	O
frequently  	frequently  	 RB	O
suffer  	suffer  	 VB	O
from  	from  	 IN	O
recurrence  	recurrence  	 NN	O
after  	after  	 IN	O
few  	few  	 JJ	O
cycles  	cycles  	 NNS	O
of  	of  	 IN	O
treatment 	treatment 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
underlying  	underlying  	 JJ	O
mechanisms  	mechanisms  	 NNS	O
causing  	causing  	 VBG	O
the  	the  	 DT	O
chemoresistance  	chemoresistance  	 NNS	B-NP
remain  	remain  	 VBP	O
unclear 	unclear 	 JJ	O
.  	.  	 .	O
Recently 	Recently 	 RB	O
,  	,  	 ,	O
The  	The  	 DT	B-NP
Cancer  	Cancer  	 NNP	I-NP
Genome  	Genome  	 NNP	I-NP
Atlas  	Atlas  	 NNP	I-NP
( 	( 	 -LRB-	O
TCGA 	TCGA 	 NNP	B-NP
)  	)  	 -RRB-	O
research  	research  	 NN	B-NP
network  	network  	 NN	I-NP
concluded  	concluded  	 VBD	O
an  	an  	 DT	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
study  	study  	 NN	I-NP
and  	and  	 CC	O
released  	released  	 VBN	O
the  	the  	 DT	O
dataset  	dataset  	 NN	B-NP
to  	to  	 TO	O
the  	the  	 DT	O
public 	public 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
TCGA  	TCGA  	 NNP	B-NP
dataset  	dataset  	 NN	I-NP
possesses  	possesses  	 VBZ	O
large  	large  	 JJ	O
sample  	sample  	 NN	O
size 	size 	 NN	O
,  	,  	 ,	O
comprehensive  	comprehensive  	 JJ	B-NP
molecular  	molecular  	 JJ	I-NP
profiles 	profiles 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
outcome  	outcome  	 NN	I-NP
information 	information 	 NN	I-NP
;  	;  	 :	O
however 	however 	 RB	O
,  	,  	 ,	O
because  	because  	 IN	O
of  	of  	 IN	O
the  	the  	 DT	O
unknown  	unknown  	 JJ	O
molecular  	molecular  	 JJ	B-NP
subtypes  	subtypes  	 NN	I-NP
in  	in  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
great  	great  	 JJ	O
diversity  	diversity  	 NN	O
of  	of  	 IN	O
adjuvant  	adjuvant  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
TCGA  	TCGA  	 JJ	I-NP
patients  	patients  	 NNS	I-NP
went  	went  	 VBD	O
through 	through 	 RP	O
,  	,  	 ,	O
studying  	studying  	 VBG	O
chemotherapeutic  	chemotherapeutic  	 JJ	B-NP
response  	response  	 NN	I-NP
using  	using  	 VBG	O
the  	the  	 DT	O
TCGA  	TCGA  	 NNP	B-NP
data  	data  	 NN	I-NP
is  	is  	 VBZ	O
difficult 	difficult 	 JJ	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
factors  	factors  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
sample  	sample  	 NN	O
batches 	batches 	 NNS	O
,  	,  	 ,	O
patient  	patient  	 JJ	O
ages 	ages 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
tumor  	tumor  	 NN	B-NP
stages  	stages  	 NNS	I-NP
further  	further  	 RBR	O
confound  	confound  	 JJ	O
or  	or  	 CC	O
suppress  	suppress  	 VB	O
the  	the  	 DT	O
identification  	identification  	 NN	B-NP
of  	of  	 IN	O
relevant  	relevant  	 JJ	O
genes 	genes 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
thus  	thus  	 RB	O
the  	the  	 DT	O
biological  	biological  	 JJ	B-NP
functions  	functions  	 NNS	I-NP
and  	and  	 CC	O
disease  	disease  	 NN	B-NP
mechanisms 	mechanisms 	 NNS	I-NP
.  	.  	 .	O
To  	To  	 TO	O
address  	address  	 VB	O
these  	these  	 DT	O
issues 	issues 	 NNS	O
,  	,  	 ,	O
herein  	herein  	 VBD	O
we  	we  	 PRP	O
propose  	propose  	 VBP	O
an  	an  	 DT	O
analysis  	analysis  	 NN	B-NP
procedure  	procedure  	 NN	I-NP
designed  	designed  	 VBN	O
to  	to  	 TO	O
reduce  	reduce  	 VB	O
suppression  	suppression  	 JJ	B-NP
effect  	effect  	 NN	I-NP
by  	by  	 IN	O
focusing  	focusing  	 VBG	O
on  	on  	 IN	O
a  	a  	 DT	O
specific  	specific  	 JJ	O
chemotherapeutic  	chemotherapeutic  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
to  	to  	 TO	O
remove  	remove  	 VB	O
confounding  	confounding  	 JJ	O
effects  	effects  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
batch  	batch  	 NN	O
effect 	effect 	 NN	O
,  	,  	 ,	O
patient 	patient 	 NN	O
's  	's  	 POS	O
age 	age 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
tumor  	tumor  	 NN	B-NP
stages 	stages 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
proposed  	proposed  	 JJ	O
procedure  	procedure  	 NN	O
starts  	starts  	 VBZ	O
with  	with  	 IN	O
a  	a  	 DT	O
batch  	batch  	 NN	O
effect  	effect  	 NN	O
adjustment 	adjustment 	 NN	O
,  	,  	 ,	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
rigorous  	rigorous  	 JJ	B-NP
sample  	sample  	 NN	I-NP
selection  	selection  	 NN	I-NP
process 	process 	 NN	I-NP
.  	.  	 .	O
Then 	Then 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
gene  	gene  	 NN	B-NP
expression 	expression 	 NN	I-NP
,  	,  	 ,	O
copy  	copy  	 NN	O
number 	number 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
methylation  	methylation  	 JJ	B-NP
profiles  	profiles  	 NNS	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
TCGA  	TCGA  	 NNP	B-NP
ovarian  	ovarian  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
dataset  	dataset  	 NNS	I-NP
are  	are  	 VBP	O
analyzed  	analyzed  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
semi-supervised  	semi-supervised  	 JJ	B-NP
clustering  	clustering  	 JJ	O
method  	method  	 NN	O
combined  	combined  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
novel  	novel  	 NN	O
scoring  	scoring  	 NN	O
function 	function 	 NN	O
.  	.  	 .	O
As  	As  	 IN	O
a  	a  	 DT	O
result 	result 	 NN	O
,  	,  	 ,	O
two  	two  	 CD	O
molecular  	molecular  	 JJ	B-NP
classifications 	classifications 	 NNS	I-NP
,  	,  	 ,	O
one  	one  	 CD	O
with  	with  	 IN	O
poor  	poor  	 JJ	O
copy  	copy  	 NN	O
number  	number  	 NN	O
profiles  	profiles  	 NNS	O
and  	and  	 CC	O
one  	one  	 CD	O
with  	with  	 IN	O
poor  	poor  	 JJ	O
methylation  	methylation  	 JJ	B-NP
profiles 	profiles 	 NNS	I-NP
,  	,  	 ,	O
enriched  	enriched  	 VBG	O
with  	with  	 IN	O
unfavorable  	unfavorable  	 JJ	O
scores  	scores  	 NNS	O
are  	are  	 VBP	O
identified 	identified 	 VBN	O
.  	.  	 .	O
Compared  	Compared  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
samples  	samples  	 JJ	O
enriched  	enriched  	 NN	O
with  	with  	 IN	O
favorable  	favorable  	 JJ	O
scores 	scores 	 NNS	O
,  	,  	 ,	O
these  	these  	 DT	O
two  	two  	 CD	O
classifications  	classifications  	 NNS	B-NP
exhibit  	exhibit  	 VBP	O
poor  	poor  	 JJ	O
progression-free  	progression-free  	 JJ	B-NP
survival  	survival  	 NN	I-NP
( 	( 	 -LRB-	O
PFS 	PFS 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
might  	might  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
poor  	poor  	 JJ	O
chemotherapy  	chemotherapy  	 JJ	B-NP
response  	response  	 NN	I-NP
specifically  	specifically  	 RB	O
to  	to  	 TO	O
the  	the  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
paclitaxel  	paclitaxel  	 NN	B-NP
and  	and  	 CC	O
carboplatin 	carboplatin 	 NN	B-NP
.  	.  	 .	O
Significant  	Significant  	 JJ	B-NP
genes  	genes  	 NNS	I-NP
and  	and  	 CC	O
biological  	biological  	 JJ	B-NP
processes  	processes  	 NNS	I-NP
are  	are  	 VBP	O
detected  	detected  	 VBN	O
subsequently  	subsequently  	 RB	O
using  	using  	 VBG	O
classical  	classical  	 JJ	B-NP
statistical  	statistical  	 JJ	I-NP
approaches  	approaches  	 NNS	I-NP
and  	and  	 CC	O
enrichment  	enrichment  	 JJ	B-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
proposed  	proposed  	 JJ	O
procedure  	procedure  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
reduction  	reduction  	 NN	O
of  	of  	 IN	O
confounding  	confounding  	 NN	O
and  	and  	 CC	O
suppression  	suppression  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
semi-supervised  	semi-supervised  	 JJ	B-NP
clustering  	clustering  	 JJ	O
method  	method  	 NN	O
are  	are  	 VBP	O
essential  	essential  	 JJ	B-NP
steps  	steps  	 NNS	I-NP
to  	to  	 TO	O
identify  	identify  	 VB	O
genes  	genes  	 NNS	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
chemotherapeutic  	chemotherapeutic  	 JJ	B-NP
response 	response 	 NN	I-NP
.  	.  	 .	O
